Natixis Advisors, L.P. Adma Biologics, Inc. Transaction History
Natixis Advisors, L.P.
- $53.5 Billion
- Q4 2024
A detailed history of Natixis Advisors, L.P. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 29,153 shares of ADMA stock, worth $463,532. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,153
Previous 17,253
68.97%
Holding current value
$463,532
Previous $345,000
44.93%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
337Shares Held
183MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$296 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$289 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$236 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$180 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$88 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.12B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...